Project Details
Description
A Phase IIa, Double-blind, Randomised, Parallel-group, Multi-centre Study to Evaluate the Analgesic Efficacy of 28 days Oral Administration of AZD2423 Compared with Placebo in Patients with Painful Diabetic Polyneuropathy
| Status | Finished |
|---|---|
| Effective start/end date | 1/20/10 → 1/17/12 |
Funding
- ASTRAZENECA
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.